Paratek Pharmaceuticals, Inc.
PRTKDelisted Sep 21, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001178711
Paratek Pharmaceuticals, Inc. was delisted on Sep 21, 2023; its insiders filed their last Form 4 on Sep 21, 2023; 66 institutions reported holding it in 13F filings for Q2 2023, worth $47.0M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Paratek Pharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 100 | 2 | 84 | −14 |
| Shares | 27.6M | 89.0K | 22.8M | −4.79M (−17.4%) |
| Value | $82.1M | $265.0K | $44.4M | −$37.4M (−45.7%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held Paratek Pharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ergoteles LLC | 228,200 | $440.0K | 0.01% |
| Assenagon Asset Management S.A. | 94,012 | $181.0K | 0.00% |
| Acadian Asset Management LLC | 92,112 | $178.0K | 0.00% |
| Qube Research & Technologies Ltd | 44,449 | $86.0K | 0.00% |
| Veritable, L.P. | 18,500 | $36.0K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 18,613 | $36.0K | 0.00% |
| LMR Partners LLP | 17,469 | $34.0K | 0.00% |
| ExodusPoint Capital Management, LP | 16,852 | $33.0K | 0.00% |
| SG Americas Securities, LLC | 13,419 | $26.0K | 0.00% |
| HighPoint Advisor Group LLC | 10,242 | $22.0K | 0.00% |
| Bayesian Capital Management, LP | 10,700 | $21.0K | 0.00% |
| EverSource Wealth Advisors, LLC | 868 | $2.00K | 0.00% |
| Harbour Investments, Inc. | 2 | $0 | 0.00% |
| Credit Suisse AG | 26 | $0 | 0.00% |
Sold out (28)
Institutions that held Paratek Pharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
Not filed for Q2 2022 yet (2)
Institutions that held Paratek Pharmaceuticals, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 80,997 | $241.0K |
| Amalgamated Financial Corp. | 7,975 | $24.0K |